Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    11.00 (1.59%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Trading Update

22 Aug 2012 07:00

RNS Number : 5048K
B.P. Marsh & Partners PLC
22 August 2012
Β 

B. P. Marsh & Partners Plc ("B. P. Marsh", the "Company" or the "Group")

Trading Update

B. P. Marsh, a niche venture capital provider to early stage financial services businesses, is pleased to provide the market with an update on trading for the six month period to 31st July 2012. Since reporting our results on 30th May 2012 and against a backdrop of continuing global economic uncertainty, the Group's investee companies have completed a number of growth-focused acquisitions. The Group's cash position has improved, following the partial realisation of the Hyperion investment, providing opportunities for provision of follow-on funding to the existing investment portfolio and for new opportunities.

On 30th May 2012 the Group announced its annual results for the year ended 31st January 2012, when the Group's Net Asset Value was Β£50.1m (equating to an NAV per share of 171p).

The Board remains committed to narrowing the discount between the share price and NAV. As part of these continuing efforts, the Board agreed in July 2012 to undertake a small share buy-back of Β£50,000, taking place in August 2012.

At 31st July 2012 the Group had cash balances of Β£3.26m. The Group additionally has access to a Directors' Loan facility of Β£4.325m, having repaid the outstanding Β£1.25m on this facility in two payments; Β£250,000 on 24th February 2012 and Β£1m on 18th June 2012. The net cash position at 31st January 2012 was Β£0.7m.

Partial Realisation

On 17th May 2012 the Group sold 1,193,500 shares in Hyperion Insurance Group Limited ("Hyperion") for a cash consideration of Β£4,535,300, representing an IRR of 40.4% on these shares since they were acquired in November 1994. B.P. Marsh will retain a 13.98% shareholding in Hyperion, having reduced its previous 18.94% stake by 2.75% as a result of this realisation, and subsequent further dilution resulting from the Windsor acquisiton.Β 

The shares were sold to an existing Hyperion shareholder, Murofo Investments S.L. ("Murofo"), increasing their shareholding to 14.46%, from 11.71%, (and who now sit at 12.48%).

Investment Portfolio

Amberglobe Limited ("Amberglobe") - Acquisition of ongoing business of Turner Butler

On 27th July 2012 Amberglobe acquired the assets of Turner & Co (GB) Limited and Turner Butler Limited, the national business sales agent. The acquisition brings together two business brokerages, Amberglobe and Turner Butler, who are leaders of the SME sales market in the UK and will create the predominant force in that sector. Turner Butler has a proven business model and has demonstrated consistent profitability despite the current economic climate.

The Group provided financing for the acquisition of the assets of Turner Butler through loan financing, which is expected to be repaid within three years.

Post this acquisition the Group's holding has been hived up into a new holding company, The Broucour Group Ltd ("Broucour"), under the same terms and equity as per the original holding in Amberglobe, with Amberglobe Limited and Turner Butler Limited as its two wholly owned trading subsidiaries.

Jonathan Newman has been appointed as the Group's nominee director on the Boards of all three companies within the Broucour group, having served previously as the Group's nominee director on the Board of Amberglobe.

The Group views the acquisition as an excellent opportunity to establish Broucour as the predominant force within the SME sales market in the UK, enabling it to capitalise on this strong positioning over the coming years.

The Broucour Group's Managing Director, Rupert Cattell said: "I am absolutely delighted with the acquisition of Turner Butler. This is a terrific brand that is very well known within the business sales market. It has a high profile, a proven business model and an excellent team of people. I have known and admired Shaun Sweeney the previous owner of Turner Butler for many years and he has created an excellent business that is the perfect sister brand to Amberglobe, since they operate in different market sectors while still sharing the same IT systems and business practices. I believe that the acquisition will allow us to become the pre-eminent business brokerage in the UK. I am also very pleased that under the terms of the deal, I will continue to work closely with Shaun following the acquisition."

Hyperion Insurance Group Limited ("Hyperion")

Howden completes acquisition of Indonesian broker

Howden Broking Group Limited, the broking subsidiary of Hyperion, completed the acquisition of Accette Insurance Group's Indonesian operation, PT Accette Brokers Asuransi on 6th August 2012. The business has been renamed PT Howden Insurance Brokers Indonesia, and will trade under the Howden brand.

Tim Coles, CEO of Howden Broking Group, commented: "With the world's fourth largest population and a robust and growing economy, Indonesia is an important global market. The huge infrastructure development currently planned and taking place in the country, combined with a growing affluent community and low levels of insurance penetration, mean that it is also a market of great opportunity which we intend to be a major part of."

Completion of acquisition of Windsor Limited ("Windsor")

Regulatory approval was granted for the acquisition by Hyperion of Windsor from its management, employees and institutional backer Hutton Collins Partners LLP and completion of the acquisition took place on 3rd July 2012

DUAL, winners of Underwriter of the Year.

The DUAL Group was named Underwriting Agency of the Year at the British Insurance Awards on 4th July 2012.

US Risk (UK) Limited - Extension of loan facility

On investment in US Risk (UK) Limited in June 2010 the Group provided a Β£1.95m loan facility for a two year term. The loan was not drawn down and on expiry, it was agreed to provide a new two year facility to July 2014. The loan is intended to enable the company to build on the successful acquisition of James Hampden International Insurance Brokers Limited and Abraxas AG in 2012 with further acquisitions and team lifts.

New Business Opportunities

The Group focuses on minority investment opportunities in financial services business, typically taking an equity stake of between 15% and 45%. The uncertain global economic outlook has created a cautious climate as entrepreneurs seek to mitigate or avoid risk and has led the Group to focus on developing existing portfolio companies and establishing a more targeted approach to investment opportunities. The combination of these factors has shaped the Group's prudent approach to new investment opportunities in recent years, however, with renewed cash reserves an upswing in the opportunity pipeline is expected.

Exit Opportunities

The Board continues to consider exit opportunities for both portfolio investments and for the Group itself as and when they may arise.

The Group will announce its interim results on Tuesday 23rd October 2012.

Β 

For further information:

Β 

B. P. Marsh & Partners Plc www.bpmarsh.co.uk

Brian Marsh OBE / Camilla Kenyon +44 (0)20 7233 3112

Β 

Nominated Adviser & Broker

Panmure Gordon

Paul Lumbis / Fred Walsh / Charles Leigh-Pemberton +44 (0)20 7459 3600

Β 

Notes to Editors:

About B. P. Marsh

B. P. Marsh's current portfolio contains nine companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

Over the past 20 years, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for at least four years.

Prior to Brian Marsh's involvement in the Company, he spent many years in insurance broking and underwriting in Lloyd's as well as the London and overseas market. He has over 30 years' experience in building, buying and selling financial services businesses, particularly in the insurance sector.

Β 

Jonathan Newman is a Chartered Management Accountant and is the Group Director of Finance and has over 15 years' experience in the financial services industry. Jonathan advises investee companies through three non-executive board appointments and evaluates new investment opportunities.

Daniel Topping is a Member of the Chartered Institute of Securities and Investment (MCSI) and an Associate Member of the Institute of Chartered Secretaries and Administrators (ACIS) having joined the Company in 2007. Dan was appointed director in 2011 and currently holds four non-executive board appointments through which he advises investee companies and he also evaluates new investment opportunities.

Camilla Kenyon was appointed as Head of Investor Relations at B. P. Marsh in February 2009, having four years' prior experience with the Company. Camilla holds two non-executive appointments, is Chair of the New Business Committee and is a Member of the Investor Relations Society.

- ends -

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTLLFSDTIILFIF
Date   Source Headline
12th Sep 20257:00 amRNSNew Investment: Supporting the Growth of XPT Group
29th Aug 20253:54 pmRNSNew Investment - Supporting the Growth of Pantheon
22nd Aug 20252:32 pmRNSDirector/PDMR Shareholding
14th Aug 20257:00 amRNSNew Investment- supporting the growth of XPT Group
11th Aug 202512:50 pmRNSHolding(s) in Company
11th Aug 202510:35 amRNSHolding(s) in Company
11th Aug 202510:35 amRNSHolding(s) in Company
7th Aug 202512:44 pmRNSHolding(s) in Company
7th Aug 20257:05 amRNSBuyback Results, Transaction in Own Shares and TVR
7th Aug 20257:00 amRNSResult of Secondary Placing
6th Aug 20254:51 pmRNSProposed Buyback
6th Aug 20254:40 pmRNSPROPOSED SECONDARY PLACING
4th Aug 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
31st Jul 20258:05 amRNSPurchase of Own Shares and Total Voting Rights
17th Jul 202512:31 pmRNSResult of AGM
16th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
15th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
14th Jul 20252:10 pmRNSHolding(s) in Company
14th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
11th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
3rd Jul 20254:30 pmRNSHolding(s) in Company
1st Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
30th Jun 20257:00 amRNSPurchase of Own Shares
30th Jun 20257:00 amRNSFollow-on equity purchase in and loan to Pantheon
24th Jun 20251:15 pmRNSNotice of AGM - correction
24th Jun 202511:39 amRNSNotice of AGM
20th Jun 202510:13 amRNSPurchase of Own Shares and Total Voting Rights
17th Jun 20257:00 amRNSNew Investment – Cameron Specialty HoldCo Limited
12th Jun 202512:30 pmRNSDirector/PDMR Shareholding
11th Jun 20254:18 pmRNSDirector/PDMR Shareholding
11th Jun 20253:33 pmRNSHolding(s) in Company
10th Jun 20254:45 pmRNSDirector/PDMR Shareholding
10th Jun 202511:30 amRNSFinal Dividend Declaration
10th Jun 20257:00 amRNSFinal Results for the Year to 31 January 2025
5th Jun 202511:15 amRNSSale of Interest in Sterling Insurance Pty Ltd
4th Jun 20252:45 pmRNSNew Investment - Amiga Speciality Holdings Limited
4th Jun 202512:23 pmRNSNotice of Annual Results and Investor Presentation
3rd Jun 202511:44 amRNSResult of Meeting
14th May 20255:34 pmRNSHolding(s) in Company
14th May 20254:53 pmRNSHolding(s) in Company
12th May 20253:17 pmRNSSecondary Share Sale
12th May 202512:15 pmRNSShare BuyBack, Notice of GM and Rule 9 Waiver
9th May 202512:49 pmRNSResult of Secondary Placing
8th May 20254:40 pmRNSProposed Secondary Placing
24th Apr 20259:59 amRNSDirector/PDMR Shareholding
23rd Apr 20257:00 amRNSNew Investment - iO Partners
17th Apr 20251:45 pmRNSNew Share Buyback Programme
16th Apr 20254:45 pmRNSSpecial Dividend Declaration
7th Apr 20252:55 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.